Incyte Corp (NASDAQ:INCY)

68.43
Delayed Data
As of Apr 20
 -0.62 / -0.90%
Today’s Change
61.30
Today|||52-Week Range
140.11
-27.75%
Year-to-Date

Today’s Trading

Previous close69.05
Today’s open69.29
Day’s range67.75 - 69.41
Volume3,355,104
Average volume (3 months)2,087,979
Market cap$19.9B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-383.33%
Earnings growth (this year)+79.27%
Earnings growth (next 5 years)+73.20%
Revenue growth (last year)+38.93%
P/E ratioNM
Price/Sales12.61
Price/Book12.21

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.04+0.05%
ALXNAlexion Pharmaceutic...-3.96-3.54%
BAXBaxter International...+0.07+0.10%
MYLMylan NV-0.09-0.22%
Data as of 4:03pm ET, 04/20/2018

Financials

Next reporting dateMay 1, 2018
EPS forecast (this quarter)-$0.07
Annual revenue (last year)$1.5B
Annual profit (last year)-$313.1M
Net profit margin-20.38%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David W. Gryska
Corporate headquarters
Wilmington, Delaware

Forecasts